WBO:MARI (Austria)  
Marinomed Biotech AG logo

Marinomed Biotech AG

€ 54.00 (0%) Oct 6
P/E:
At Loss
P/B:
0
Market Cap:
€ 81.33M ($ 79.77M)
Enterprise V:
€ 92.98M ($ 91.19M)
Volume:
172.00
Avg Vol (2M):
461.00
Also Trade In:
Volume:
172.00
Market Cap €:
81.33M
Market Cap $:
79.77M
PE Ratio:
At Loss
Avg Vol (2-Month):
461.00
Enterprise Value €:
92.98M
Enterprise Value $:
91.19M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal spray, virus-blocking lozenges and virus-blocking throat spray.
Name Current Vs Industry Vs History
Cash-To-Debt 0.49
Equity-to-Asset -0.08
Debt-to-Equity -11.77
Debt-to-EBITDA -9.56
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.04
Distress
Grey
Safe
Beneish M-Score -3.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.45
9-Day RSI 23.49
14-Day RSI 29.06
6-1 Month Momentum % -24.81
12-1 Month Momentum % -46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.98
Quick Ratio 2.74
Cash Ratio 1.96
Days Inventory 53.94
Days Sales Outstanding 86.88
Days Payable 45.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 1.6
Name Current Vs Industry Vs History
Gross Margin % 26.74
Operating Margin % -17.37
Net Margin % -40.21
ROA % -24.7
ROIC % -18.26
ROC (Joel Greenblatt) % -36.97
ROCE % -18.22
Name Current Vs Industry Vs History
PS Ratio 6.02
EV-to-EBIT -30.69
EV-to-EBITDA -39.16
EV-to-Revenue 6.98
EV-to-FCF -50.33
Earnings Yield (Greenblatt) % -3.26

Financials

WBO:MARI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 13.313
EPS (TTM) (€) -3.587
Beta 0.14
Volatility % 22.4
14-Day RSI 29.06
14-Day ATR (€) 2.100874
20-Day SMA (€) 59.7
12-1 Month Momentum % -46
52-Week Range (€) 52.4 - 110.5
Shares Outstanding (Mil) 1.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Marinomed Biotech AG Filings

Document Form Filing Date
No Filing Data

Marinomed Biotech AG Analysis

Share your research